Comments on: Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care https://wfhcfl.org/switching-to-dolutegravir-lamivudine-two-drug-regimen-durability-and-virologic-outcomes-by-age-sex-and-race-in-routine-us-clinical-care/ A Non-Profit Health Center Mon, 13 May 2024 13:19:59 +0000 hourly 1